Phase II, randomized, double-blind, placebo-controlled, multicenter study to investigate the immunogenicity and safety of a West Nile virus vaccine in healthy adults.

Source:http://linkedlifedata.com/resource/pubmed/id/21148499

J. Infect. Dis. 2011 Jan 1 203 1 75-84

Download in:

View as

General Info

PMID
21148499